Guidance on COVID-19

20-0044
Type: Rules Notice > Guidance Note
Rule connection:
UMIR
Legacy DMR Rules
Distribute internally to:
Legal and Compliance
Senior Management
Trading Desk
Registration
Ultimate Designated Persons
Chief Compliance Officers

Contact:

Levi Sankar
Director, General Counsel’s Office
Telephone:
Email:

The health and safety of all market participants is of paramount importance to IIROC. In response to the risks associated with  COVID-19, investment firms are considering the effects of a potential global pandemic on their client service and regulatory obligations, with some taking pre-emptive measures.

We expect firms to continue to meet their regulatory obligations. 

IIROC recognizes that some level of regulatory flexibility may be required to enable its Members to best serve investors and maintain market stability.  If Members are able to meet the requirements from backup sites or with staff working from home, IIROC has no objection as long as appropriate measures are in place for supervisory, confidentiality and other regulatory requirements. IIROC will work with Members to address any client and regulatory concerns resulting from the effects of a pandemic.

IIROC is reviewing examination schedules and moving to off-site exams, where feasible.

In addition, there are a number of IIROC standing and advisory committees in place.   Rather than hosting these meetings on site, we will use video and tele-conferencing for the foreseeable future.

While the precise impact of a pandemic is impossible to predict, when dealing with a pandemic, Members may need to modify or enhance Business Continuity Plan (BCP)1 solutions established primarily to deal with other types of disruptive events. Consistent with Dealer Member Rule 17.16, Members should carefully and regularly monitor publicly available information from reputable sources, such as government web sites, considering the scope and geographic location of their own operations to ensure continued client service and compliance with all applicable regulatory requirements. References to publicly available reputable information and guidance sources concerning pandemics and COVID-19 are provided below.

A pandemic is different from other significant disruptive events in several important respects including:

  • Duration and location - pandemics do not happen suddenly but typically develop over a period of time, for extended periods, and impact different and often shifting geographic locations
  • Business effects - pandemics may result in high rates of absenteeism and disruption to supply chains and business travel
  • Protection of employees, customers and other stakeholders - pandemics require controls to mitigate the risks of infection in a workplace including training staff on mitigation strategies2, consideration of amendments to or relief from internal sick day policies, and consideration of alternate meeting arrangements, such as videoconferencing, with clients and counterparties
  • Financial effects - pandemics may result in a fall in demand for goods and services and have human resource, insurance and cash flow implications.

Vulnerabilities to telecommunication disruptions, particularly in work-from-home arrangements3, may be mitigated through obtaining dedicated or premium broadband service for the homes of critically important employees.  Firms should consider building layers of redundancy through multiple carriers and/or the use of communication tools such as personal digital assistants, laptops and tablets in a secure environment. Members may also consider reviewing and potentially updating their service-level agreements with critical counterparties and vendors to address the potential impacts of a pandemic.

We encourage Members to contact their IIROC relationship manager to discuss any concerns.

Additional Sources of Information

Federal

Public Health Agency of Canada
https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection.html

Global Affairs Canada
https://www.international.gc.ca/world-monde/issues_development-enjeux_developpement/global_health-sante_mondiale/pandemics-pandemies.aspx?lang=eng

Canadian Centre for Occupational Health and Safety
https://www.ccohs.ca/outbreaks/

Provincial

Ontario Public Health
https://www.publichealthontario.ca/en/diseases-and-conditions/infectious-diseases/respiratory-diseases/novel-coronavirus

BC Centre for Disease Control
http://www.bccdc.ca/health-info/diseases-conditions/coronavirus-(novel)

Alberta Health Services
https://www.alberta.ca/coronavirus-info-for-albertans.aspx

Government of Quebec
https://www.quebec.ca/en/health/health-issues/a-z/2019-coronavirus/

Government of Nova Scotia
https://novascotia.ca/coronavirus/

Government of New Brunswick
https://www2.gnb.ca/content/gnb/en/departments/ocmoh/cdc/content/respiratory_diseases/coronavirus.html

Government of Prince Edward Island
https://www.princeedwardisland.ca/en/information/health-and-wellness/coronavirus-covid-19-infection-frequently-asked-questions

Government of Saskatchewan
https://www.saskatchewan.ca/government/health-care-administration-and-provider-resources/treatment-procedures-and-guidelines/emerging-public-health-issues/2019-novel-coronavirus

Government of Manitoba
https://www.gov.mb.ca/health/coronavirus/

Government of Yukon
https://yukon.ca/en/information-about-novel-coronavirus-yukoners

Government of Northwest Territories
https://www.hss.gov.nt.ca/en/services/coronavirus-disease-covid-19

Government of Nunavut
https://www.gov.nu.ca/health/information/communicable-disease

Government of Newfoundland Labrador
https://www.health.gov.nl.ca/health/publichealth/cdc/coronavirus/

United States of America

Centers for Disease Control and Prevention (CDC):
https://www.cdc.gov/coronavirus/2019-ncov/index.html

International

World Health Organization (WHO)
https://www.who.int/emergencies/diseases/novel-coronavirus-2019